News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 8, 2011

The Current Controversies and Opportunities in Reproductive Medicine

Author(s)Lateef Akinola, PhD, MRCOG, MBA, Lateef Akinola, PhD, MRCOG, MBA

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Subfecundity, not IVF, linked to elevated neurodevelopmental risk in offspring | Image credit: stock.adobe.com.

Subfecundity, not IVF, linked to elevated neurodevelopmental risk in offspring

ByJoshua Fitch, Senior Editor

July 6th 2026

Closing fertility care gaps: A Q&A with Esther H. Chung, MD, FACOG

Closing fertility care gaps: A Q&A with Esther H. Chung, MD, FACOG

ByEsther H. Chung, MD, FACOG

May 28th 2026

FDA approves progesterone vaginal inserts bioequivalent to Endometrin

ByBenjamin P. Saylor

April 9th 2026

Weekly review: Preserving fertility in patients with cancer; GSL, and high stroke risk in pregnancy | Image credit: stock.adobe.com.

Weekly review: Preserving fertility in patients with cancer; GSL, and high stroke risk in pregnancy

ByJoshua Fitch, Senior Editor

March 16th 2026

FAQs: ASCO guideline on fertility preservation in people with cancer | Image credit: stock.adobe.com.

FAQs: ASCO guideline on fertility preservation in people with cancer

ByJoshua Fitch, Senior Editor

March 12th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

CDC: 15% of US women report drinking alcohol during pregnancy

CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD